IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.
Free access to all Sound Bites content
Published Dec 13, 2024
Medical Professional
PIONEER- Efficacy
Dr. Amer Zeidan describes the patient management with luspatercept including RS negative and EPO <200 (Video 3/3)
Amer Zeidan, MD
Dr. Himisha Beltran describes the safety of PARP inhibitors in treating BRCA2 mutations in prostate cancer (Video 3/3)
Himisha Beltran, MD
Dr. Martin Dietrich describes the safety of trastuzumab deruxtecan and practical strategies for managing adverse effects (Video 3/3)
Martin Dietrich
Dr. Edgardo Santos reviews the impact of SQ amivantamab in EGFRm mNSCLC (Video 2/3)
Edgardo Santos, MD
Dr. Joshua Reuss describes the safety of zongertinib in patients with HER2mutated advanced lung cancer (Video 3/3)
Joshua Reuss, MD
Dr. Manali Kamdar reviews the appropriate patient profiles for liso-cel in R/R LBCL (Video 2/3)
Manali Kamdar, MD